Consensus Guidelines for CSF and Blood Biobanking for CNS Biomarker Studies

Area of Science:

• Neurology
• Biomarker Research
• Neuroinflammation

Background:

• Cerebrospinal fluid (CSF) biomarkers are vital for neurodegenerative and neuroinflammatory diseases, yet few are clinically utilized.
• Current diagnostics like anti-aquaporin-4 antibodies for neuromyelitis optica (NMO) highlight the need for prognostic and treatment-response CSF biomarkers.
• Single-center studies often lack statistical power, necessitating collaborative efforts for robust biomarker discovery.

Purpose of the Study:

• To present consensus guidelines for standardized cerebrospinal fluid (CSF) collection and biobanking.
• To address pre-analytical factors that compromise the statistical power of multi-center biomarker studies.
• To provide protocols applicable to CSF biobanks for any neurological disease research.

Main Methods:

• Development of consensus guidelines based on existing BioMS-eu network protocols.
• Focus on standardized CSF collection procedures and pre-analytical considerations.
• Emphasis on collecting high-quality clinical and paraclinical data alongside CSF samples.

Main Results:

• Established consensus guidelines for CSF collection and biobanking.
• Detailed recommendations for minimizing pre-analytical variability.
• Provided a framework for creating robust CSF biobanks for neurological research.

Conclusions:

• Standardized CSF biobanking protocols are essential for overcoming limitations in current biomarker research.
• Collaboration and adherence to standardized protocols will enhance the power and reliability of neurological disease biomarker studies.
• These guidelines support the development of effective CSF biomarker strategies for diverse neurological conditions.